Breast implants linked to rare cancer are removed from European marketBMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k5401 (Published 20 December 2018) Cite this as: BMJ 2018;363:k5401
- Deborah Cohen
- London, UK
One of the world’s best selling types of silicone breast implants, which have been linked to a rare form of atypical lymphoma (BIA-ALCL), have been removed from the market across Europe.
The recall of Allergan textured implants came after the French national agency for the safety of medicines and health products (ANSM) said it was suspending the Conformité Européene (CE) mark for Allergan’s Microcell and Biocell products.
It means that, for now, the implants cannot be manufactured or sold in Europe and those held at clinics are being recalled.
French authorities said they had not “identified any immediate risk for the …